Jeil Pharma Holdings Inc (002620.KS) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 5Aug 10Aug 13Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−9.5x

Market Cap

KRW 122.19B

MomentumView details →

1D Return

+1.19%

YTD Return

−4.35%

RSI (14)

61.0

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−9.5x

Market Cap

KRW 122.19B

RSI (14)

61.0

MomentumView details →

1D Return

+1.19%

YTD Return

−4.35%

ProfitabilityView details →

Gross Margin

39.48%

Net Margin

1.35%

EBITDA Margin

−6.37%

ROE (TTM)

2.68%

ROA (TTM)

0.95%

Asset Turnover

0.70x

GrowthView details →

Revenue YoY

−15.40%

EPS YoY

+124.06%

FCF YoY

+90.12%

Revenue CAGR 3Y

−6.05%

EPS CAGR 3Y

+128.69%

EBITDA YoY

—

EarningsView details →

EPS (Actual)

KRW 71.83

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Capital & dividendView details →

Debt/Equity

0.59x

Current Ratio

1.20x

Quick Ratio

0.85x

Div Yield

0.92%

Div Rate

KRW 70.00

Div Growth 1Y

+40.00%

Financials snapshotView financials →

Revenue (TTM)

622.49B

Net Income (TTM)

8.43B

Op. CF (TTM)

11.86B

Latest newsMore news →

No recent news for 002620.KS.

Similar companies

Chong Kun Dang Holdings Corp.001630.KS SAMSUNG PHARM. Co., Ltd.001360.KS Yuyu Pharma, Inc.000227.KS Samil Pharmaceutical Co.,Ltd000520.KS Kyongbo Pharmaceutical Co., Ltd214390.KS HANDOK Inc.002390.KS Find similar companies →

Latest newsMore news →

No recent news for 002620.KS.